GGrantIndex
Sort

78,016 grants matching breast cancer

EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES

$604,916
University Of Wisconsin Madison · U10 · FY2002 · CA

(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.

$604,910
Theresa A Guise · Indiana University Indianapolis · R01 · FY2019 · CA

Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model

$604,817
Istvan Jozsef Merchenthaler · University Of Maryland Baltimore · R01 · FY2024 · AG

Exploiting ferroportin for cancer imaging and therapy

$604,800
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

Predicting Endocrine Therapy Response In Male Breast Tumors

$604,746
Philip M Spanheimer · Univ Of North Carolina Chapel Hill · R37 · FY2024 · CA

Understanding the biological basis for the association between parenchymal texture features and breast cancer risk

$604,724
Sarah Jane Nyante · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Advanced Breast Imaging: Trends and Outcomes Associated with Recent Breast Density Reporting Legislation

$604,724
Natasha Kay Stout · Harvard Pilgrim Health Care, Inc. · R01 · FY2017 · CA

Consortium Study to Identify Breast Cancer Susceptibility Loci

$604,723
Wei Zheng · Vanderbilt University · R01 · FY2013 · CA

A RCT TO PROMOTE MAMMOGRAPHY ADHERENCE AMONG CHINESE IMMIGRANT WOMEN

$604,713
Judy Huei-Yu Wang · Georgetown University · R01 · FY2012 · CA

Effects of a telehealth exercise program for rural cancer survivors with cancer-related fatigue including integrated longitudinal assessments of objective physical function and fatty acid oxidation

$604,703
Ryan J Marker · University Of Colorado Denver · R01 · FY2025 · CA

SAN FRANCISCO MAMMOGRAPHY REGISTRY--A RESEARCH RESOURCE

$604,509
University Of California San Francisco · U01 · FY2003 · CA

IMMUNE REGULATION OF BREAST CANCER METASTASIS DORMANCY

$604,500
University Of California, San Diego · · FY2018 · Department of the Army

Regulators of Cancer Immunotherapy Response

$604,374
Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2021 · CA

Novel Technology for the Analysis of Gene Expression

$604,343
Ambergen, Inc · R44 · FY2002 · CA

DC City-wide Patient Navigation Research Program

$604,338
Steven R Patierno · George Washington University · U01 · FY2006 · CA

CAREER: Dysfunctional Osteocyte Mechanoresponse in Tumor-induced Bone Disease

$604,321
Maureen E Lynch · University Of Colorado At Boulder · · FY2021 · ENG

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology

$604,320
Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

Proteolytic Control of Oncoprotein Function

$604,307
William Patrick Tansey · Cold Spring Harbor Laboratory · P01 · FY2010 · CA

Cancer In the Jerusalem Perinatal Study

$604,299
Columbia University Health Sciences · R01 · FY2004 · CA

HSET as a racial disparity biomarker for TNBC patients

$604,281
Ritu Aneja · Georgia State University · R01 · FY2021 · CA

OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY

$604,272
Gregory M Lanza · Washington University · R01 · FY2019 · CA

Microwave Imaging for Neoadjuvant Chemotherapy Monitoring

$604,200
Paul M Meaney · Dartmouth College · R01 · FY2019 · CA

Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation

$604,191
Toshihiro Shioda · Massachusetts General Hospital · R01 · FY2025 · ES

EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES

$604,169
University Of Wisconsin Madison · U10 · FY2004 · CA

FOCUSED ULTRASOUND-MEDIATED MECHANICAL DESTRUCTION TO ENHANCE THERAPEUTIC RESPONSES IN METASTATIC BREAST CANCER

$603,955
Rector & Visitors Of The University Of Virginia · · FY2019 · Defense Health Agency